RT @RichardPAConway: Brevet et al. SAPHO syndrome. Divided into bone group and joint/mixed group. Better response to bis
Tweet Content
Brevet et al. SAPHO syndrome. Divided into bone group and joint/mixed group. Better response to bisphosphonate in bone group 60% vs 6%. Better response to DMARD in joint/mixed group 94% vs 40% @RheumNow #EULAR2022 POS1333 https://t.co/FfYBIEGGgJ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off